×
Cerus Common Stock Net 2010-2024 | CERS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cerus common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
View More
Cerus Common Stock Net 2010-2024 | CERS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cerus common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$194.8B
Boston Scientific (BSX)
$139.8B
Stryker (SYK)
$139.4B
EssilorLuxottica (ESLOY)
$110.1B
Medtronic (MDT)
$103.4B
Lonza Group Ag (LZAGY)
$43.7B
Haleon (HLN)
$41.2B
GE HealthCare Technologies (GEHC)
$38.7B
ResMed (RMD)
$34.3B
Terumo (TRUMY)
$28B
Koninklijke Philips (PHG)
$24.3B
Zimmer Biomet Holdings (ZBH)
$20.8B
Insulet (PODD)
$19.1B
Baxter (BAX)
$15B
Smith & Nephew SNATS (SNN)
$10.5B
Bio-Rad Laboratories (BIO)
$9.6B
BellRing Brands (BRBR)
$9.1B
Demant (WILYY)
$8.6B
Lantheus Holdings (LNTH)
$6.7B
Haemonetics (HAE)
$3.9B
ICU Medical (ICUI)
$3.8B
Prestige Consumer Healthcare (PBH)
$3.7B
Perrigo (PRGO)
$3.3B
Envista Holdings (NVST)
$3.2B
QuidelOrtho (QDEL)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
Neogen (NEOG)
$2.7B
GN Store Nord (GNNDY)
$2.6B
LeMaitre Vascular (LMAT)
$2.1B
Green Thumb Industries (GTBIF)
$1.6B